Cancer Clinical Trial
— CAPADOGEVerified date | November 2017 |
Source | University Hospital, Bordeaux |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators will propose to older cancer patients with good prognosis (curative care) a randomized trial of adapted physical activity during one year. To increase generalisation of the intervention the investigators intend to compare the PNNS advices (the French National Nutrition and Health Program) to a program targeted on the own capacities of each patient.
Status | Completed |
Enrollment | 302 |
Est. completion date | June 10, 2016 |
Est. primary completion date | June 10, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility |
Inclusion Criteria: - 70 years old or older - Curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/ or radiotherapy - Patient with histologically proven lymphoma or carcinoma : - Colon, rectum or anal canal Cancer - Breast Cancer - Esophageal cancer - Otolaryngology Cancer - Kidney cancer - hepatocellular carcinoma - Stomach Cancer - Pancreatic cancer - Bile duct cancer - Ovarian Cancer - All lymphoma diffuse large B-cell and all peripheral T-cells lymphomas - All low-grade lymphoma: lymphocytes, lymphocytes and plasma cells, follicular, mantle, marginal zone (MALT and others) - Prostate cancer - Bladder Cancer - Lung cancer - adenocarcinoma of unknown primary origin compatible with previous quoted origin - Performance status (ECOG) <4 - Patient who had given oral consent to participate in the study Exclusion Criteria: - Palliative cares for cancer |
Country | Name | City | State |
---|---|---|---|
France | CHU de Bordeaux - Hôpital Saint André | Bordeaux | |
France | Institut Bergonié | Bordeaux | |
France | CH de Dax | Dax | |
France | Centre Oscar Lambret, CLCC Lille | Lille | |
France | CHRU Lille | Lille | |
France | CHU de Limoges, Hôpital Dupuytren | Limoges | |
France | CH Mont de Marsan | Mont de Marsan | |
France | CHU Bordeaux - hôpital Xavier Arnozan | Pessac | |
France | Institut jean Godinot, CLCC Reims | Reims | |
France | Centre hospitalier de Senlis | Senlis | |
France | Centre Alexis Vautrin CLCC Nancy | Vandœuvre-Les-Nancy | |
France | CHU Nancy hôpital adulte du brabois | VandÅ“uvre-Les-Nancy |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Bordeaux |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SPPB Score | The main outcome will be the proportion of subjects with a one-year decreased SPPB score of one point or more in 12. | 1 year | |
Primary | Cognitive skills | MMS test, verbal fluency | 2 years | |
Secondary | Quality of life | IPAQ, QLQ-C30, ADL, performance status (ECOG) | 2 years | |
Secondary | nutritional status | 2 years | ||
Secondary | Walking distance over 6 minutes | inclusion, 6 months and 1 year | ||
Secondary | isometric muscle strength measures of upper and lower limbs | microfet2 test | 2 years | |
Secondary | weight | 2 years | ||
Secondary | SPPB score | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|